Viridian Therapeutics, Inc. (VRDN)
17.62
+0.17
(+0.97%)
USD |
NASDAQ |
May 29, 16:00
17.82
+0.20
(+1.14%)
After-Hours: 20:00
Viridian Therapeutics Total Liabilities (Quarterly) : 153.01M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 83.31B |
| Spyre Therapeutics, Inc. | 93.14M |
| Praxis Precision Medicines, Inc. | 50.24M |
| CAMP4 Therapeutics Corp. | 74.56M |
| Savara, Inc. | 45.61M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 789.02M |
| Shareholders Equity (Quarterly) | 636.01M |
| Debt to Equity Ratio | 0.0805 |
| Current Ratio | 15.15 |
| Net Debt Paydown Yield | -0.28% |